TCM
LEGN icon

TimesSquare Capital Management’s Legend Biotech LEGN Stock Holding History

TimesSquare Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,912
Closed -$94.8K – 153
2024
Q4 		$94.8K Sell
2,912
-1,156,518
-100% -$47.9M ﹤0.01% 150
2024
Q3 		$56.5M Sell
1,159,430
-14,336
-1% -$764K 0.85% 44
2024
Q2 		$52M Buy
1,173,766
+15,266
+1% +$704K 0.82% 46
2024
Q1 		$65M Buy
1,158,500
+92,611
+9% +$5.58M 0.94% 37
2023
Q4 		$64.1M Buy
1,065,889
+142,118
+15% +$9.01M 0.94% 38
2023
Q3 		$62M Buy
923,771
+4,779
+0.5% +$332K 0.97% 34
2023
Q2 		$63.4M Sell
918,992
-144,618
-14% -$9.45M 0.91% 40
2023
Q1 		$51.3M Buy
1,063,610
+117,110
+12% +$5.73M 0.75% 52
2022
Q4 		$47.2M Buy
946,500
+5,200
+0.6% +$252K 0.67% 63
2022
Q3 		$38.4M Buy
941,300
+849,800
+929% +$39.9M 0.53% 88
2022
Q2 		$5.03M Buy
91,500
+5,500
+6% +$232K 0.07% 172
2022
Q1 		$3.13M Buy
+86,000
New +$3.4M 0.04% 193
2020
Q3 		– Sell
-134,100
Closed -$5.71M – 241
2020
Q2 		$5.71M Buy
+134,100
New +$5.24M 0.05% 203

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

TimesSquare Capital Management's LEGN Position: Q1 2025 in Review

TimesSquare Capital Management sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 2,912 shares — an estimated $94.8K sold.

TimesSquare Capital Management first reported a position in LEGN in Q2 2020 and held it in 13 quarters. The position peaked at $65M in Q1 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • TimesSquare Capital Management reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • TimesSquare Capital Management sold 2,912 Legend Biotech shares in Q1 2025, an estimated $94.8K.
  • TimesSquare Capital Management first reported a position in Legend Biotech in Q2 2020 and held it in 13 quarters.
  • TimesSquare Capital Management's Legend Biotech position peaked at $65M in Q1 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on TimesSquare Capital Management's 13F filing for Q1 2025, filed 2 May 2025.